Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Overgaard

Showing results (91-100 of 389) with videos related to

Pageof 39
Sort By:
Acta Oncologica (Stockholm, Sweden)|May 7, 2016
Pattern of relapse after breast conserving therapy, a study of 1519 early breast cancer patients treated in the Central Region of Denmark 2000-2009Anne Bodilsen, Birgitte V Offersen, Peer Christiansen, et al.
EJNMMI Radiopharmacy and Chemistry|June 17, 2020
In vitro hypoxia responsiveness of [<sup>18</sup>F] FDG and [<sup>18</sup>F] FAZA retention: influence of shaking versus stagnant conditions, glass versus polystyrene substrata and cell number down-scalingMorten Busk, Michael R Horsman, Jens Overgaard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2003
Prediction of normal tissue radiosensitivity from polymorphisms in candidate genesChristian Nicolaj Andreassen, Jan Alsner, Marie Overgaard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 26, 2024
ESHO 1-85. Hyperthermia as an adjuvant to radiation therapy in the treatment of locally advanced breast carcinoma. A randomized multicenter study by the European Society for Hyperthermic OncologyJens Overgaard, Maarten Ccm Hulshof, Olav Dahl, et al.
Molecular Oncology|May 29, 2020
What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyondMichael Baumann, Nadja Ebert, Ina Kurth, et al.
Journal of Experimental Therapeutics & Oncology|October 22, 2003
Low-dose total body irradiation augments the therapeutic effect of interleukin-2 in a mouse model for metastatic malignant melanomaAkmal Safwat, Ninna Aggerholm, Ivan Roitt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 22, 2007
Hypoxia induced expression of endogenous markers in vitro is highly influenced by pHBrita Singers Sørensen, Jan Alsner, Jens Overgaard, et al.
Acta Oncologica (Stockholm, Sweden)|August 14, 2015
Validation of a gene expression profile predictive of the risk of radiation-induced fibrosis in women treated with breast conserving therapyChristina D Lyngholm, Jens Overgaard, Peer M Christiansen, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2004
Tumour burden and interleukin-2 dose affect the interaction between low-dose total body irradiation and interleukin 2Akmal Safwat, Ninna Aggerholm, Ivan Roitt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2011
Dependence of cell survival on instantaneous dose rate of a linear acceleratorBrita Singers Sørensen, Anne Vestergaard, Jens Overgaard, et al.
Pageof 39

Showing results (91-100 of 389) with videos related to

Sort By:
Pageof 39
Acta Oncologica (Stockholm, Sweden)|May 7, 2016
Pattern of relapse after breast conserving therapy, a study of 1519 early breast cancer patients treated in the Central Region of Denmark 2000-2009Anne Bodilsen, Birgitte V Offersen, Peer Christiansen, et al.
EJNMMI Radiopharmacy and Chemistry|June 17, 2020
In vitro hypoxia responsiveness of [<sup>18</sup>F] FDG and [<sup>18</sup>F] FAZA retention: influence of shaking versus stagnant conditions, glass versus polystyrene substrata and cell number down-scalingMorten Busk, Michael R Horsman, Jens Overgaard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2003
Prediction of normal tissue radiosensitivity from polymorphisms in candidate genesChristian Nicolaj Andreassen, Jan Alsner, Marie Overgaard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 26, 2024
ESHO 1-85. Hyperthermia as an adjuvant to radiation therapy in the treatment of locally advanced breast carcinoma. A randomized multicenter study by the European Society for Hyperthermic OncologyJens Overgaard, Maarten Ccm Hulshof, Olav Dahl, et al.
Molecular Oncology|May 29, 2020
What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyondMichael Baumann, Nadja Ebert, Ina Kurth, et al.
Journal of Experimental Therapeutics & Oncology|October 22, 2003
Low-dose total body irradiation augments the therapeutic effect of interleukin-2 in a mouse model for metastatic malignant melanomaAkmal Safwat, Ninna Aggerholm, Ivan Roitt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 22, 2007
Hypoxia induced expression of endogenous markers in vitro is highly influenced by pHBrita Singers Sørensen, Jan Alsner, Jens Overgaard, et al.
Acta Oncologica (Stockholm, Sweden)|August 14, 2015
Validation of a gene expression profile predictive of the risk of radiation-induced fibrosis in women treated with breast conserving therapyChristina D Lyngholm, Jens Overgaard, Peer M Christiansen, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2004
Tumour burden and interleukin-2 dose affect the interaction between low-dose total body irradiation and interleukin 2Akmal Safwat, Ninna Aggerholm, Ivan Roitt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2011
Dependence of cell survival on instantaneous dose rate of a linear acceleratorBrita Singers Sørensen, Anne Vestergaard, Jens Overgaard, et al.
Pageof 39